GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (BOM:544210) » Definitions » PB Ratio

Emcure Pharmaceuticals (BOM:544210) PB Ratio : 6.24 (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-14), Emcure Pharmaceuticals's share price is ₹1359.25. Emcure Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ₹217.79. Hence, Emcure Pharmaceuticals's PB Ratio of today is 6.24.

Good Sign:

Emcure Pharmaceuticals Ltd stock PB Ratio (=6.3) is close to 1-year low of 6.3

The historical rank and industry rank for Emcure Pharmaceuticals's PB Ratio or its related term are showing as below:

BOM:544210' s PB Ratio Range Over the Past 10 Years
Min: 6.3   Med: 8.8   Max: 9.56
Current: 6.44

During the past 4 years, Emcure Pharmaceuticals's highest PB Ratio was 9.56. The lowest was 6.30. And the median was 8.80.

BOM:544210's PB Ratio is ranked worse than
86.81% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs BOM:544210: 6.44

During the past 12 months, Emcure Pharmaceuticals's average Book Value Per Share Growth Rate was 43.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.50% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Emcure Pharmaceuticals was 7.50% per year. The lowest was 7.50% per year. And the median was 7.50% per year.

Back to Basics: PB Ratio


Emcure Pharmaceuticals PB Ratio Historical Data

The historical data trend for Emcure Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals PB Ratio Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
PB Ratio
- - - -

Emcure Pharmaceuticals Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
PB Ratio Get a 7-Day Free Trial - - - - 6.77

Competitive Comparison of Emcure Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emcure Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Emcure Pharmaceuticals's PB Ratio falls into.



Emcure Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Emcure Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=1359.25/217.79
=6.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Emcure Pharmaceuticals  (BOM:544210) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Emcure Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Emcure Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines